Recent advances in adrenocortical carcinoma in adults.

  title={Recent advances in adrenocortical carcinoma in adults.},
  author={Isabelle Bourdeau and Jessica Mackenzie-Feder and Andr{\'e} Lacroix},
  journal={Current opinion in endocrinology, diabetes, and obesity},
  volume={20 3},
PURPOSE OF REVIEW Adrenocortical cancer (ACC) is a rare and often aggressive malignancy. The overall 5-year survival rate of ACC is less than 30% in part owing to advanced stage of the disease at diagnosis and limited efficiency of therapies when initial surgery is not curative. So far, studies with large cohorts of patients affected by ACC were lacking because of the rarity of the disease; however, recent international and multicenter collaborative studies provide new insights in the… CONTINUE READING